Daniel Mark Schwartz - 03 Aug 2021 Form 4 Insider Report for RxSight, Inc. (RXST)

Role
Director
Signature
/s/ Shelley Thunen, as Attorney-in-Fact
Issuer symbol
RXST
Transactions as of
03 Aug 2021
Net transactions value
$0
Form type
4
Filing time
05 Aug 2021, 19:49:33 UTC
Previous filing
29 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXST Common Stock Conversion of derivative security $0 +3,969 +0.98% $0.000000 407,647 03 Aug 2021 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RXST Series C Preferred Stock Conversion of derivative security $0 -3,872 -100% $0.000000* 0 03 Aug 2021 Common Stock 3,969 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Daniel Mark Schwartz is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 All shares of the Series C Preferred Stock, par value $0.001 per share, of the Issuer automatically converted on a one-for-1.0251 basis to shares of the Issuer's common stock, par value $0.001 per share ("Common Stock") immediately prior to the closing of the Issuer's initial public offering of its Common Stock.
F2 The number of shares reported as beneficially held by the Reporting Person in the Form 3 filed July 29, 2021 incorrectly overstated the number of shares held by 11,012 shares. The correct number of shares should have been reported as 403,678.